Reuters logo
BRIEF-Morphosys says Janssen received US FDA approval for Tremfya for treatment of plaque psoriasis
July 13, 2017 / 9:24 PM / 2 months ago

BRIEF-Morphosys says Janssen received US FDA approval for Tremfya for treatment of plaque psoriasis

July 13 (Reuters) - Morphosys Ag

* Morphosys announces that its licensee janssen has received us FDA approval for Tremfya for the treatment of moderate to severe plaque Psoriasis

* Licensee Janssen biotech has reported that U.S. Food and drug administration has approved Tremfya

* Morphosys will receive a milestone payment from janssen in connection with BLA approval

* Financial details were not disclosed Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below